UNSPSC 51343505: Adefovir pivoxil

This classification denotes a reverse transcriptase inhibitor with the molecular formula C20H32N5O8P, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier U6Q8Z01514, chemically known as adefovir di(pivaloyloxymethyl) ester [mi], but more generally known as adefovir pivoxil, which bears US NIH Compound Identifier 60871. European Medicines Agency schedules adefovir pivoxil or its base in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05264MIG.

Most nations, for tariff purposes, schedule adefovir pivoxil under HS 29335995. SMILES: CC(C)(C)C(=O)OCOP(=O)(COCCN1CNC2C1NCNC2N)OCOC(=O)C(C)(C)C.

UNSPSC 51343505 Adefovir pivoxil is a Commodity code that nominally covers a specific antiviral pharmaceutical product, but recent state and local procurement activity under this code shows little relevant purchasing. The two most recent opportunities posted under the code involve naloxone and drug deactivation systems (Seminole County, Florida) and doxycycline and ciprofloxacin tablets (Illinois Department of Public Health), neither of which are adefovir pivoxil or closely related products. State and local governments do procure pharmaceuticals through piggyback contracts and cooperative purchasing vehicles, but the specific product scope of this code has generated no clearly matching solicitations in the recent record. When pharmaceutical codes are tagged to misaligned opportunities, it often reflects broad vendor platform contracts or miscategorization in the posting system rather than genuine demand for the named product.

The limited recent activity appears concentrated in Florida and Illinois, with purchases flowing through established cooperative purchasing consortia like MMCAP Infuse and county competitive bidding processes. The Illinois Department of Public Health awarded a three-year piggyback contract to Chartwell Rx LLC totaling $2,999,999.11 through an Invitation for Bid in August 2026, and Seminole County issued an IFB in June 2026 for naloxone and drug deactivation systems with quarterly delivery requirements. Neither opportunity directly aligns with adefovir pivoxil procurement. If your firm supplies this specific pharmaceutical product to state or local health departments, wholesalers, or correctional facilities, monitor state health department RFPs and cooperative purchasing vehicle updates directly rather than relying on this code's recent posting history, as the tagging signal is presently weak.